scocal.stanford.edu/opinion/bristol-myers-squibb-co-v-super-ct-34514

Aug 29, 2016 ... BRACY ANDERSON et al., ... Bristol-Myers Squibb Company (BMS), a pharmaceutical .... 754]; Goodyear Dunlop Tires Operations, S.A. v.

www.law360.com/cases/58e6506f2a2edd2f07000001

Parties, docket activity and news coverage of federal case Bristol-Myers Squibb Company et al v. Mylan Pharmaceuticals Inc., case number 1:17-cv-00379, from  ...

www.classaction.org/media/brazil-v-bristol-meyers.pdf

Jan 13, 2016 ... v. Bristol-Myers Squibb Company,. Otsuka Pharmaceutical Co., Ltd., and ..... 28 Eric Hollander et al.., Pathological Gambling, 23(3) THE PSYCHIATRIC .... Cochrane Database of Systematic Reviews, THE COCHRANE ...

law.justia.com/cases/federal/appellate-courts/ca6/16-3154/16-3154-2017-10-27.html

Oct 27, 2017 ... Relators, former BMS employees, alleged in a qui tam suit that BMS and Otsuka engaged in a ... Relators allege that, despite those agreements, the companies continued to ... Ibanez v. Bristol-Myers Squibb Co., No. 16-3154 (6th Cir. 2017) ... 16-3154 U.S. ex rel. Ibanez v. Bristol-Myers Squibb, et. al. Page 2 ...

www.supremecourt.gov/opinions/16pdf/16-466_1qm1.pdf

Jun 19, 2017 ... OF CALIFORNIA, SAN FRANCISCO COUNTY, ET AL. CERTIORARI TO ... Bristol -Myers Squibb Company (BMS) in California state court, al-.

www.patentdocs.org/2019/02/momenta-pharmaceuticals-inc-v-bristol-myers-squibb-co-fed-cir-2019.html

Feb 7, 2019 ... ImmunoGen, Inc.; E. I. du Pont de Nemours & Co. v. ... Momenta Pharmaceuticals , Inc. v, Bristol-Myers Squibb Co. (Fed. ... The case involved a inter partes review ( IPR) brought by Momenta against all claims of U.S. Patent No.

www.bms.com/researchers-and-partners/our-r-and-d-team/research-publications.html

All-Cause, Stroke/Systemic Embolism-, and Major Bleeding-Related Health-Care ..... Outcomes at 7 years post-transplant in black vs nonblack kidney transplant recipients ...... Bethesda (MD): Eli Lilly & Company and the National Center for Advancing ...... in patients with impaired renal function: response to Hellfritzsch et al.